Exhibit 10.6


 


employment
agreement


 


Executed on this 1st day of March, 2019


 


This Employment Agreement (the “Agreement”)
is entered into by and between ChemomAb Ltd. with its principal place of business at Kiryat Atidim, Building 7, Tel-Aviv,
Israel (the “Company”) and Arnoa Aharon, whose address is at Yavne 12, Tel-Aviv, Israel (the “Executive”).


 


EMPLOYMENT AND COMPENSATION


 


		1.	The Company has agreed to employ Executive for an indefinite period and Executive has agreed to
become so employed, on the terms and conditions set forth herein. The commencement date of the employment, Executive’s position,
the reporting duties and other work-related terms, including salary, entitlements and fringe benefits, are specified in Appendix
A attached hereto.



 


		2.	Executive undertakes to devote Executive’s full time, attention, skill, and effort exclusively
to the performance of Executive’s duties and undertakes not to engage, whether as an employee or otherwise, in any business,
commercial or professional activities, whether or not for compensation, during Executive’s employment, without the prior
written consent of the Company; provided, however, that the Executive may provide, from time to time, paid or unpaid consulting
services without the prior approval of the Company for so long as such services (a) do not infringe the Executive’s duties
under the terms of Executive’s employment as set forth herein, (b) do not raise any conflict of interest with the Executive’s
duties under the terms of Executive’s employment as set forth herein, and (c) do not exceed three (5) hours per week unless
otherwise agreed to in writing by the Company. Nothing contained herein shall derogate from Executive’s undertakings in Appendix
B attached hereto,



 


		3.	This Agreement may be terminated by either party at any time by giving the other party hereto a
prior notice of such termination, as specified in Appendix A (the “Notice Period”).



 


		4.	Notwithstanding anything to the contrary in Section 3 above, the Company may terminate the Executive’s
employment for Cause. In any event of termination for Cause, the Employment under this Agreement shall forthwith terminate and
thereafter the Company shall not have any further liability or obligation towards Executive, including with respect to Notice Period.
The term “Cause” means: (i) breach of Executive’s fiduciary duties, misappropriation of the Company’s
property or any breach of Executive’s undertakings under Appendix B; or (ii) a material breach by the
Executive of this Agreement, provided however, that Executive has not cured such breach (if remediable) within 7 days following
a notice sent to Executive by the Company; or (iii) Executive’s indictment for a criminal offense (other than an offense
for which a fine or non-custodial penalty is imposed) or involvement in sexual harassment of another employee or third party in
connection with Executive’s employment; or (in) any other circumstances under which prior notice may be denied from Executive
upon termination of employment under any applicable law.



 


		5.	Executive shall have no lien on any of the Company’s assets, equipment or any other material
in Executive’s possession. Executive shall return to the Company all Company’s equipment no later than the day of termination
of employer-employee relationship, prior to any unpaid leave or within 7 days following Company’s demand.



 


		6.	Nothing herein shall derogate from any right Executive may have, in accordance with any law, expansion
order, collective bargaining agreement, employment agreement or any other agreement with respect to the terms of Executive’s
employment, which cannot be stipulated against.



 






    1


     


    

 


SPECIAL POSITION


 


		7.	It is agreed that the Executive’5 position is a management one and/or which requires a special
degree of personal trust, as defined in the Working Hours and Rest Law, 1951 (the “Working Hours and Rest Law”).
Therefore, Executive shall not be granted any other compensation or payment other than expressly specified in Appendix
A. Executive undertakes not to claim that the Working Hours and Rest Law applies to Executive’s employment
with the Company. Executive acknowledges the legitimacy of the Company’s requirement to work “overtime” or during
 “weekly rest-hours” without being entitled to “overtime compensation” or “weekly rest-hour compensation”
(as these terms are defined in the Working Hours and Rest Law), and Executive undertakes to reasonably comply with such requirements
of the Company. Executive acknowledges that the compensation to which Executive is entitled pursuant to this Agreement constitutes
adequate compensation for Executive’s work during “overtime” or “weekly rest-hours”.



 


NON DISCLOSURE, COMPETITIVE ACTIVITY
AND OWNERSHIP OF INVENTIONS


 


		8.	Simultaneously with the signing of this Agreement, Executive shall sign the Non-Disclosure, Unfair
Competition and Ownership of Inventions Undertaking in favor of the Company, attached hereto as Appendix B.



 


EXECUTIVE’S REPRESENTATIONS
AND UNDERTAKINGS


 


Executive represents, warrants, and undertakes
all of the following:


 


		9.	Executive has the ability, knowledge and qualifications needed to perform Executive’s obligations
under this Agreement. Executive does not suffer from any physical or mental health issues which may have an unreasonable influence
on the performance of Executive’s undertakings under this Agreement.



 


		10.	There are no other undertakings or agreements preventing, restricting or limiting the fulfillment
of Executive’s obligation5 under this Agreement. Executive shall not, by entering into this Agreement and performing Executive’s
obligations hereunder, be deemed to be: (i) violating any right of Executive’s former employer(s), or (ii) in breach of or
in conflict with, any of Executive’s obligations towards Executive’s former employer(s) or under any agreement or obligation
to which Executive is bound.



 


		11.	Executive shall inform the Company of any matter in which Executive or Executive’s immediate
family has a personal interest and which might give rise to a company of interest with Executive’s duties under the terms
of Executive’s employment, immediately upon becoming aware of such matter.



 


		12.	Executive shall not receive any benefit from any third party, directly or indirectly in connection
with Executive’s employment. In the event Executive breaches this undertaking, without derogating from any of the Company’s
rights, such benefit or its value shall become the sole property of the Company and the Company may deduct the value of such benefit
from any payment Executive may be entitled to. This section does not apply to gifts or benefits with insignificant value.



 


		13.	In carrying out Executive’s duties, Executive shall not act in a way which contradicts the
signature rights of the Company.



 


		14.	Executive acknowledges and agrees that from time to time Executive may be required by the Company
to travel and stay abroad as part of Executive’s obligations under this Agreement.



 


		15.	For the performance of Executive’s duties, the Company may provide Executive with a PC, laptop,
software, hardware, email address and/or mobile phone, as applicable (the “Company’s Computers”), which
will be the sole property of the Company. Subject to the Company’s applicable policies and without derogating from Executive’s
undertakings or performance of his/her duties according to this Agreement, the Executive may be entitled to make reasonable personal
use of the Company’s Computers, provided that the Executive may not store personal material on the Company’s Computers
(except on folders clearly labeled as “Personal”). It is hereby clarified that the Executive has previously
provided certain services to the Company, in the capacity of a consultant, and has used his personal laptop (the “Private
Computer”) for the provision of such services. Until such time that the Company provides the Executive with an alternative
laptop and the Executive agrees to use such laptop provided by the Company, the Executive shall continue to use the Private Computer
for the performance of his duties towards the Company as set forth herein. It is clarified that the professional email account
shall be strictly used for professional matters, whereas for personal matters the Executive may use external email services (such
as Gmail).



 


		16.	Executive acknowledges and agrees as follows: (i) the Company may allow other employees and third
parties to use the Company’s Computers; (ii) to protect the Company’s legitimate interests, the Company may monitor
the use of the Company’s Computers, including by inspections of email transmissions, internet usage and inspections of their
content and use its findings as evidence in any legal proceedings; (iii) in light of Executive’s undertakings above, the
Executive shall have no right to privacy in any content stored on the Company’s Computers, except with respect to folders
clearly labeled as “Personal”.



 






    2


     


    

 


		17.	Executive acknowledges and agrees that information related to the Executive and the Executive’s
terms of employment at the Company, as shall be received and held by the Company (the “Information”), may be
transferred to third parties, including those located abroad, subject to: (a) that such transfer shall be made only in order for
the Company to comply with any relevant legal requirements or due to business purposes of the Company (including transactions related
with the Company); (b) that the transferred Information shall be limited to the reasonable and necessary scope; and (c) that the
receiver of the Information shall undertake, to the extent possible, to preserve the privacy of the Information, at least at the
level of privacy kept by the Company itself regarding the Information.



 


		18.	In the event this Agreement is terminated for any reason whatsoever, Executive shall cooperate
with the Company and exercise Executive’s best efforts to assist in the integration of the person or persons who will assume
Executive’s responsibilities into the Company.



 


GENERAL PROVISIONS


 


		19.	This Agreement and all Appendices a9ached hereto constitute the entire agreement between the parties
and supersede all prior agreements, proposals, understandings and arrangements, if any, whether oral or written, between the parties
hereto with respect to the subject matter hereof. This Agreement may be amended, supplemented or modified only by a written instrument
duly signed by or on behalf of each party hereto.



 


		20.	This Agreement shall be governed by and construed in accordance with the laws of the State of Israel,
without giving effect to its laws pertaining to conflict of laws. Any and all disputes in connection with this Agreement shall
be submitted to the exclusive jurisdiction of the competent courts or tribunals, as relevant, located in the city of Tel-Aviv-Jaffa,
Israel.



 


		21.	Any notice or other communication in connection with this Agreement must be in writing to the address
set forth in the preamble to this Agreement (or to such other address as shall be specified by like notice), sent via registered
mail, messenger or email. Such notice shall be deemed given after four (4) business days, if sent via registered mail; after one
(1) day if sent by messenger, provided a proof of delivery has been received; after one (1) day if sent by email, provided however,
that a computerized automatic “received” approval (delivery receipt) was sent by the email server.



 


	Executive acknowledges that: (1) he has read and fully understood all the provisions of this Agreement and its appendices; (2) he was given the opportunity to consult with third parties, including his attorneys; (3) This Agreement was signed at Executive’s own free will.


 






    3


     


    

 


appendix
a



terms of employment and compensation


 


		1.	Commencement Date, Position and Reporting - Executive’s employment shall commence
on March 1st, 2019, in a full-time position as Chief Medical Officer (CMO). Executive shall report directly to CEO.



 


		2.	Notice Period Two months (60 days). Notwithstanding the above, the Company shall
be entitled to consider the Executive’s clear and unequivocal oral notice of resignation as binding, in the absence of written
notice.



 


		3.	Salary - A gross monthly salary of NIS 55,000 (the “Salary”).
The Salary shall be payable on such dates as required by law.



 


Any payment or benefit under
this Appendix A, other than the Salary, shall not be considered as a salary for any purpose whatsoever,
and the Executive shall not maintain or claim otherwise.


 


		4.	Bonus - Upon completion of 12 months of Executive’s employment, the Company will adopt
a personal bonus policy according to which the Executive will be entitled to an annual bonus of up to 20% of the Executive’s
annual Salary, provided that the Executive has successfully fulfilled all of the objectives set forth in such personal bonus policy.
Both the objectives and the degree of compliance with them shall be determined by the Company at its sole discretion.



 


		5.	Pension Arrangements - The Company shall insure the Executive under an accepted ‘Managers’
Insurance’ plan (the “Managers’ Insurance Policy”), a Pension Fund (the “Pension Fund”)
or a combination of both, at Executive’s choice, according to the following rates and conditions:



 


		5.1	Managers’ Insurance Policy:



 


		5.1.1	Disability Insurance - The Company, at its own discretion and expense, shall purchase a disability
insurance, under normal and acceptable conditions, which would insure 75% of the Salary (the “Disability Insurance”).
The Company’s contribution for Disability Insurance shall, in no circumstances, exceed the amount of 21/20/0 of the Salary.



 


		5.1.2	Severance - an amount equal to 8’/% of the Salary;



 


		5.1.3	Company’s contribution towards pension - the difference between 6.5% of the Salary and the
actual percentage of the Salary contributed towards Disability Insurance, provided that the Company’s contribution towards
pension shall not be lesser than 5% of the Salary.



 


		5.1.4	Executive’s contribution towards pension - 6% of the Salary.



 


		5.2	Pension Fund: Severance - an amount equal to 8 1/3% of the Salary; Pension - an amount equal
to 6.5% of the Salary. In addition, the Company will deduct from Executive’s monthly paycheck a sum equal to 6% of the Salary
as Executive’s contribution.



 


		6.	Pension Funds Release - The Company and Executive agree to adopt the provisions of
the “General Approval of the Minister of Labor and Social Welfare Regarding Payments by Employers to a Pension Fund and Insurance
Fund in lieu of Severance Pay”, which was issued in accordance with the Severance Pay Law, 1963 (the “General Acknowledgement”),
as amended from time to time. The General Acknowledgment is attached to this Agreement as Appendix C. The
Company waives any right that it may have for the repayment of any monies paid by it to the Managers’ Insurance Policy and/or
the Pension Fund, unless the right of Executive to severance has been revoked by a judicial decision, under Section 16 or 17 of
the Severance Pay Law, 1963 (to the extent of such revocation) or in case Executive withdrew monies from the Pension Fund or the
Insurance Fund for any reason other than death, disability or retirement at the age of sixty or thereafter.



 






    4


     


    

 


Executive hereby acknowledges
and confirms that the Company’s contributions towards the Executive’s Insurance Policy and/or the Pension Fund are
and shall be in lieu of severance pay, if Executive shall be entitled to such, according to Section 14 of the Severance Pay Law,
1963 and in accordance with the General Acknowledgement.


 


		7.	Study Fund(“Keren Hishtalmut”) Following 3 months of employment, the Company
and Executive shall maintain a ‘Keren Hishtalmut’ Fund (the “Keren Hishtalmut Fund”). The Company
shall contribute to such Keren Hishtalmut Fund an amount equal to 7.5% of the Salary, and the Executive shall contribute to such
Keren Hishtalmut Fund an amount equal to 2.5% of the Salary provided, however, that the contributions according to this section
shall not exceed the maximum tax-exempt amount prescribed by the Income Tax Ordinance. Executive hereby instructs the Company to
transfer to such Keren Hishtalmut Fund the amount of Executive’s contribution from each Salary.



 


		8.	Vacation - Executive shall be entitled to 22 working days as vacation days (the “Vacation
Days”), with respect to each full year of continuous employment with the Company but no less than the amount required
by the provisions of the Annual Leave Law, 1951 (the “Leave Law”), as amended from time to time. Executive shall
be entitled to carry forward the unused Vacation Days in accordance with the terms set out in the Leave Law. Any contractual vacation
days (annual leave days granted in excess of the amount required by law or by any applicable expansion order) remaining unused
at the end of any 12-month period of employment, shall be forfeited with no compensation payable.



 


		9.	Sick Leave - Executive shall be entitled to full sick leave from the first day of
absence. In the event Executive is absent from work due to illness, Executive shall notify the Company of the illness on the first
day of absence, unless Executive is unable to provide such notice due to Executive’s medical condition, in which case the
notice will be delivered as soon as possible. Such notice shall include, inter alia, the estimated period in which Executive will
be absent from work.



 


		10.	Recuperation Pay - Executive shall be entitled to Recuperation Pay (“Dmey Havra’a”)
in accordance with the applicable expansion order.



 


Options Subject
to the sole discretion and determination of the Company and approval of such grant by the board of directors of the Company (the
 “Board”) at its discretion, and subject to the consummation of a financing round of the Company, Executive shall
be granted an option to purchase such number of ordinary shares of the Company representing, together with options previously granted
to the Executive by the Company (under any capacity), 1% of the issued share capital of the Company following the consummation
of the closing of the next financing round of the Company including any extension to such round and/or subsequent closing/s (the
 “Options”), subject to any dilution occurring following the next financing round. The Options shall be issued
under and subject to the terms of any share-based incentive plan and option agreement adopted by the Company (the “ESOP”),
and are conditional upon execution of an option agreement in a form provided by the Company and all other required documents and
agreements required by the Company. The Options exercise price shall be as determined by the Board and the Options shall vest in
accordance with the terms of the ESOP or as otherwise determined by the Board. Executive undertakes to take all actions and to
sign all documents required, at the discretion of the Company, in order to give effect to and enforce the above terms and conditions.
Any taxes and compulsory payments in connection with the Options (including with respect to the grant, exercise or sale of the
Options or the shares receivable upon their exercise) shall be borne solely by Executive.


 


		11.	Travel Allowance - Executive shall be entitled to a gross payment of NIS 3,000 for his travel
allowance, in accordance with applicable law.



 


		12.	Business Expenses - The Company shall reimburse Executive for necessary and customary business
expenses incurred by Executive, in accordance with the Company’s policy, as amended from time to time. The Executive shall
be entitled to flight tickets reimbursement of up to 4000USD for transatlantic flights, all according to the Company’s standard
rules.



 


		13.	Taxes - The Company shall withhold, deduct, transfer and/or charge Executive with
all taxes and other compulsory payments as required under law in respect of, or resulting from, the compensation paid to or received
by Executive and in respect of all the benefits that Executive is or may be entitled to.



 






    5


     


    

 


Appendix
B


 


THIS UNDERTAKING (“Undertaking”)
is entered into as of the 27 day of February, 2019, by Arnon Aharon, whose address is at Yavne 12, Tel-Aviv, Israel (the
 “Executive”).


 


WHEREAS, Executive wishes to be
employed by ChemomAb Ltd. (the “Company”); and


 


WHEREAS, it is critical for the
Company to preserve and protect its Confidential Information (as defined below) and its rights in Inventions (as defined below)
and in all related intellectual property, and Executive is entering into this Undertaking as a condition to Executive’s employment
with the Company.


 


NOW, THEREFORE, the Executive undertakes
and warrants towards the Company as follows:


 


References herein to the term “Company”
shall include any of the Company’s direct or indirect parent, subsidiary and affiliated companies, and their respective successors
and assigns.


 


		1.	Confidentiality.



 


		1.1	Executive acknowledges that Executive may have access to information that relates to the Company,
its business, assets, financial condition, affairs, activities, plans and projections, customers, suppliers, partners, and other
third parties with whom the Company agreed or agrees, from time to time, to hold information of such party in confidence (the “Confidential
Information”). Confidential Information shall include, without limitation, information, whether or not marked or designated
as confidential, concerning technology, products, research and development, patents, copyrights, inventions, trade secrets, test
results, formulae, processes, data, know-how, marketing, promotion, business and financial plans, policies, practices, strategies,
surveys, analyses and forecasts, financial information, customer lists, agreements, transactions, undertakings and data concerning
employees, consultants, officers, directors, and shareholders. Confidential Information includes information in any form or media,
whether documentary, written, oral, magnetic, electronically transmitted, through presentation or demonstration or computer generated.
Confidential Information shall not include information that: (i) has become part of the public domain not as a result of a breach
of any obligation owed by Executive to the Company; or (ii) is required to be disclosed by law or the binding rules of any governmental
organization, provided, however, that Executive gives the Company prompt notice thereof so that the Company may seek a protective
order or other appropriate remedy, and further provided, that in the event that such protective order or other remedy is not obtained,
Executive shall furnish only that portion of the Confidential Information which is legally required, and shall exercise all reasonable
efforts required to obtain confidential treatment for such information.



 


		1.2	Executive acknowledges and understands that the employment by the Company and the access to Confidential
Information creates a relationship of confidence and trust With respect to such Confidential Information.



 


		1.3	During the term of Executive’s employment and at any time after termination or expiration
thereof, for any reason, Executive shall keep in strict confidence and trust, shall safeguard, and shall not disclose to any person
or entity, nor use for the benefit of any party other than the Company, any Confidential Information, other than with the prior
express consent of the Company.



 


		1.4	All right, title and interest in and to Confidential Information are and shall remain the sole
and exclusive property of the Company or of the third party providing such Confidential Information to the Company, as the case
may be. Without limitation of the foregoing, Executive agrees and acknowledges that all memoranda, books, notes, records, email
transmissions charts, formulae, specifications, lists and other documents (contained on any media whatsoever) made, reproduced,
compiled, received, held or used by Executive in connection with the employment by the Company or that otherwise relates to any
Confidential Information (the “Confidential Material”), shall be the Company’s sole and exclusive property
and shall be deemed to be Confidential Information. All originals, copies, reproductions and summaries of the Confidential Materials
shall be delivered by Executive to the Company upon termination or expiration of Executive’s employment for any reason, or
at any earlier time at the request of the Company, without Executive retaining any copies thereof.



 






    6


     


    

 


		1.5	During the term of Executive’s employment with the Company, Executive shall not remove from
the Company’s offices or premises any Confidential Material unless and to the extent necessary in connection with the duties
and responsibilities of Executive and permitted pursuant to the then applicable policies and regulations of the Company. In the
event that such Confidential Material is duly removed from the Company’s offices or premises, Executive shall take all actions
necessary in order to secure the safekeeping and confidentiality of such Confidential Material and return the Confidential Material
to their proper files or location as promptly as possible after such use,



 


		1.6	During the term of Executive’s employment with the Company, Executive will not improperly
use or disclose any proprietary or confidential information or trade secrets, and will not bring onto the premises of the Company
any unpublished documents or any property, belonging to any former employer or any other person to whom Executive has an obligation
of confidentiality and/or non-use (including, without limitation, any academic institution or any entity related thereto), unless
generally available to the public or consented to in writing by that person.



 


		2.	Unfair Competition and Solicitation.



 


		2.1	Executive undertakes that during the term of employment with the Company Executive shall not engage,
establish, open or in any manner whatsoever become involved, directly or indirectly, either as an employee, owner, partner, agent,
shareholder, director, consultant or otherwise, in any business, occupation, work or any other activity which competes with the
business of the Company.



 


		2.2	Executive undertakes that for a period of twelve (12) months following termination of Executive’s
employment for whatever reason Executive shall not engage, establish, open or in any manner whatsoever become involved, directly
or indirectly, either as an employee, owner, partner, agent, shareholder, director, consultant or otherwise, in any business, occupation,
work or any other activity which is reasonably likely to involve or require the use of any of the Company’s Major Assets,
as defined below. Executive confirms that engagement, establishment opening or involvement, directly or indirectly, either as an
employee, owner, partner, agent, shareholder, director, consultant or otherwise, in any business, occupation s work or any other
activity which competes with the business of the Company as conducted during the term of employment or contemplated, during such
term, to be conducted, is likely to require the use of all or a portion of the Company’s Major Assets.



 


		2.3	Executive hereby declares that he/she is aware that a portion of the Salary contains additional
consideration in exchange for the Executive fully undertaking the non-compete provisions in Sections 2.1 and 2.2 above. Notwithstanding
anything in this provision, the Executive declares that he/she is financially capable of undertaking these non-compete provisions.



 


		2.4	Executive undertakes that during the term of employment with the Company and for a period of twelve
(12) months thereafter: (i) Executive shall not, directly or indirectly, solicit, hire or retain as an employee, consultant or
otherwise, any employee of the Company or induce or attempt to induce any such employee to terminate or reduce the scope of such
employee’s employment with the Company; and (ii) Executive shall not, directly or indirectly, solicit or induce, or attempt
to solicit or induce, any consultant, service provider, agent, distributor, customer or supplier of the Company to terminate, reduce
or modify the scope of such person’s engagement with the Company.



 






    7


     


    

 


		2.5	Executive acknowledges that in light of Executive’s position with the Company and in view
of Executive’s exposure to, and involvement in, the Company’s sensitive and valuable proprietary information, property
(including, intellectual property) and technologies, as well as its goodwill and business plans (the “Company’s
Major Assets”), the provisions of this Section 2 above are reasonable and necessary to legitimately protect the Company’s
Major Assets, and are being undertaken by Executive as a condition to the employment of Executive by the Company. Executive confirms
that Executive has carefully reviewed the provisions of this Section 2, fully understands the consequences thereof and has assessed
the respective advantages and disadvantages to Executive of entering into this Undertaking and, specifically, Section 2 hereof.



 


		3.	Ownership of Inventions.



 


		3.1	Executive will notify and disclose in writing to the Company, or any persons designated by the
Company from time to time, all information, improvements, inventions, trademarks, works, designs, trade secrets, formulae, processes,
techniques, know-how and data, whether or not patentable or registerable under copyright or any similar laws, made or conceived
or reduced to practice or learned by Executive, either alone or jointly with others, during Executive’s employment with the
Company (including after hours, on weekends or during vacation time) (all such information, improvements, inventions, trademarks,
works, designs, trade secrets, formulae, processes, techniques, know-ho> e and data are hereinafter referred to as the “Invention(s)”)
immediately upon discovery, receipt or invention as applicable.



 


		3.2	Executive agrees that all the Inventions are, upon creation, Inventions of the Company, shall be
the sole property of the Company and its assignees, and the Company and its assignees shall be the sole owner of all title, rights
and interest in and to any patents, copyrights, trade secrets and all other rights of any kind or nature, including moral rights,
in connection with such Inventions. Executive hereby irrevocably and unconditionally assigns to the Company all the following with
respect to any and all Inventions: (i) all title, rights and interest in and to any patents, patent applications, and patent rights,
including any and all continuations or extensions thereof; (ii) rights associated with works of authorship, including copyrights
and copyright applications, Moral Rights (as defined below) and mask work rights; (iii) rights relating to the protection of trade
secrets and confidential information; (iv) design rights and industrial property rights; (v) any other proprietary rights relating
to intangible property including trademarks, service marks and applications thereof, trade names and packaging and all goodwill
associated with the same; (vi) any and all title, rights and interest in and to any Invention; and (vii) all rights to sue for
any infringement of any of the foregoing rights and the right to all income, royalties, damages and payments with respect to any
of the foregoing rights. Executive also hereby forever waives and agrees never to assert any and all Moral Rights Executive may
have in or with respect to any Inventions, even after termination of employment on behalf of the Company. “Moral Rights”
means any right to claim authorship of a work, any right to object to any distortion or other modification of a work, and any similar
right, existing under the law of any country in the world, or under any treaty.



 


		3.3	Executive has attached hereto, as Exhibit B-1, a list describing all information,
improvements, inventions, formulae, processes, techniques, know-how and data, whether or not patentable or registerable under copyright
or any similar laws, and whether or not reduced to practice, original works of authorship and trade secrets made or conceived by
or belonging to the Executive (whether made solely by the Executive or jointly with others) that: (i) were developed by the Executive
prior to the Executive’s engagement with the Company (collectively, the “Prior Inventions”), (ii) relate
to the Company’s actual or proposed business, products or research and development, and (iii) are not assigned to the Company
hereunder; or, if Exhibit B-1 is incomplete or if no such list is attached, the Executive represents that there are
no such Prior Inventions.



 


		3.4	Executive further agrees to perform, during and after employment, all acts deemed reasonably necessary
or desirable by the Company to permit and assist it, at the Company’s expense, in obtaining, maintaining, defending and enforcing
the Inventions in any and all countries. Such acts may include, but are not limited to, execution of documents and assistance or
cooperation in legal proceedings. Executive hereby irrevocably designates and appoints the Company and Its duly authorized officers
and agents, as Executive’s agents and attorneys-in-fact to act for and on Executive’s behalf and instead of Executive,
to execute and file any documents and to do all other lawfully permitted acts to further the above purposes with the same legal
force and effect as if executed by Executive.



 






    8


     


    

 


		3.5	Executive shall not be entitled to any monetary consideration or any other consideration except
as explicitly set forth in the employment agreement between Executive and the Company. Without limitation of the foregoing, Executive
irrevocably confirms that the consideration explicitly set forth in the employment agreement is in lieu of any rights for compensation
that may arise in connection with the Inventions under applicable law and waives any right to claim royalties or other consideration
with respect to any Invention, including under Section 134 of the Israeli Patent Law - 1967. Any oral understanding, communication
or agreement with respect to the matters set forth herein, not memorialized in writing and duly signed by the Company, shall be
void.



 


		4.	General.



 


		4.1	Executive represents that the performance of all the terms of this Undertaking and Executive’s
duties as an employee of the Company does not and will not breach any invention assignment, proprietary information, non-compete,
confidentiality or similar agreements with, or rules, regulations or policies of, any former employer or other party (including,
without limitation, any academic institution or any entity related thereto). Executive acknowledges that the Company is relying
upon the truthfulness and accuracy of such representations in employing Executive.



 


		4.2	Executive acknowledges that the provisions of this Undertaking serve as an integral part of the
terms of Executive’s employment and reflect the reasonable requirements of the Company in order to protect its legitimate
interests with respect to the subject matter hereof.



 


		4.3	Executive recognizes and acknowledges that in the event of a breach or threatened breach of this
Undertaking by Executive, the Company may suffer irreparable harm or damage and will, therefore, be entitled to injunctive relief
to enforce this Undertaking (without limitation to any other remedy at law or in equity).



 


		4.4	This Undertaking is governed by and construed in accordance with the laws of the State of Israel,
without giving effect to its laws pertaining to conflict of laws. Any and all disputes in connection with this Undertaking shall
be submitted to the exclusive jurisdiction of the competent courts or tribunals, as relevant, located in the city of Tel-Aviv-Jaffa,
Israel.



 


		4.5	If any provision of this Undertaking is determined by any court of competent jurisdiction to be
invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent
of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Undertaking
only with respect to such jurisdiction in which such clause or provision cannot be enforced, and the remainder of this Undertaking
shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been
contained in this Undertaking. In addition, if any particular provision contained in this Undertaking shall for any reason be held
to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing
the scope of such provision so that the provision is enforceable to the fullest extent compatible with applicable law.



 


		4.6	The provisions of this Undertaking shall continue and remain in full force and effect following
the termination or expiration of the employment relationship between the Company and Executive, for whatever reason. This Undertaking
shall not serve in any manner so as to derogate from any of Executive’s obligations and liabilities under any applicable
law.



 


		4.7	Executive hereby consents that, following the termination or expiration of the employment relationship
hereunder, the Company may notify the Executive’s new employer about the Executive’s rights and obligations under this
Undertaking.



 






    9


     


    

 


		4.8	This Undertaking constitutes the entire agreement between Executive and the Company with respect
to the subject matter hereof and supersedes all prior agreements, proposals, understandings and arrangements, if any, whether oral
or written, with respect to the subject matter hereof. No amendment, waiver or modification of any obligation under this Undertaking
will be enforceable unless set forth in a writing signed by the Company. No delay or failure to require performance of any provision
of this Undertaking shall constitute a waiver of that provision as to that or any other instance. No waiver granted under this
Undertaking as to any one provision herein shall constitute a subsequent waiver of such provision or of any other provision herein,
nor shall it constitute the waiver of any performance other than the actual performance specifically waived.



 


		4.9	This Undertaking, the rights of the Company hereunder, and the obligations of Executive hereunder,
will be binding upon and inure to the benefit of their respective successors, assigns, heirs, executors, admini5trators and legal
representatives. The Company may assign any of its rights under this Undertaking. Executive may not assign, whether voluntarily
or by operation of law, any of its obligations under this Undertaking, except with the prior written consent of the Company.



 


IN WITNESS WHEREOF, the
undersigned, has executed this Undertaking as of the date first mentioned above.


 


	 	Arnon Aharon:	/s/ Arnon Aharon	 



 






    10


     


    

 


APPENDIX
C


 


General Approval Regarding Payments by
Employers to a

Pension Fund and Insurance Fund in lieu of Severance Pay 


 


In accordance with the Severance Pay Law
5723-1963


 


By virtue of my authority under Section
14 of the Severance Pay Law 5723-1963 (hereinafter, the “Law”), 1 hereby confirm that payments made by an employer
beginning on the date this authorization is publicized, for its employee, towards a comprehensive pension in a provident fund for
benefit payments, which is not an insurance fund as implied in the Income Tax Regulations (Rules for Approving and Managing Provident
Funds) 5724-1964 (hereinafter, a “Pension Fund”), or towards Managers’ Insurance that includes an option for
benefit payments (hereinafter, an “Insurance Fund”) or a combination of payments towards a Pension Fund and an Insurance
Fund (hereinafter, “Employer Payments”), shall be in lieu of the severance pay to which the said employee is entitled
for the wages of which the said payments were paid and the period for which they were paid (hereinafter, the “Exempted Salary”),
provided the following conditions shall be met:


 


		1.	Employer Payments -



 


		(a)	To a Pension Fund are not less than 14.33% of the Exempted Salary or 12% of the Exempted Salary
if the employer pays for its employee, in addition to this, supplementary severance payments towards a Severance Pay Fund or an
Insurance Fund in the name of the employee, at a rate of 2.33% of the Exempted Salary. If the employer does not pay the said 2.33%
in addition to the 12%, its payments shall be only in lieu of 720/o of the employee’s severance pay.



 


		(b)	To an Insurance Fund are not less than one of the following:



 


		(1)	13 1/3% of the Exempted Salary, if the employer pays for its employee payments for additional monthly
income support in case of employee’ s inability to work, through a plan approved by the Supervisor for Capital Markets, Insurance
and Savings in the Ministry of Finance, at a rate necessary to guarantee at least 75% of the Exempted Salary, or at a rate of 2
1/2o o of the Exempted Salary, whichever is lower (hereinafter, “Loss of Work Capacity Insurance”).



 


		(2)	11% of the Exempted Salary, if the employer paid an additional Payment for the Loss of Work Capacity
Insurance, and in such case the employer’s payments shall be only in lieu of 72% of the employee’s severance pay. If,
in addition to such payments, the employer has also paid payments for the supplement of severance pay to a Severance Pay Fund or
an Insurance Fund under the name of the employee at a rate of 2 1/3% of the Exempted Salary, the employer’s payments shall
be in lieu of 100% of the employee’s severance pay.



 


		2.	Not later than three months from the commencement of the employer’s payments a written agreement
shall be prepared between the employer and the employee, which shall include:



 


		(a)	The employee’s agreement to an arrangement in accordance with this authorization, in wording
that specifies the employer’s payments and the Pension Fund and the Insurance Fund, as relevant. The said agreement shall
also include the wording of this authorization.



 


		(b)	The employer’s prior waiver of any right it may have to a financial reimbursement for all
or part of its payments, unless the employee’s right to severance pay is rescinded by a judicial decree by virtue of Sections
16 or 17 of the Law, or that the employee withdrew funds from the Pension Fund or from the Insurance Fund not for a qualifying
incident. In this regard a “qualifying incident” - death, disability or retirement at the age of 60 or older.



 






    11


     


    

 


		(c)	This authorization shall not derogate from the employee’s right to severance pay under the
Law, collective agreement, expansion order or employment contract, for wages exceeding The Exempted Salary.



 


	 	Eliyahu Yishai
	 	Minister of Labor and Social Welfare



 






    12